Concept paper for the development of a guideline on the demonstration of therapeutic equivalence for nasal products
Dossier requirements for anticancer medicinal products for dogs and cats - Scientific guideline
Concept paper on the revision of the guideline on dossier requirements for anticancer medicinal products for dogs and cats
New fee regulation: webinar for veterinary marketing authorisation holders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 June 2024, 10:00 (CEST) to 20 June 2024, 11:00 (CEST)
Records of data processing activity for digital business cards (QR code)
Orphan designation: Acetylleucine Treatment of ataxia-oculomotor apraxia, 16/04/2024 Positive
Orphan designation: annamycin Treatment of acute myeloid leukaemia, 16/04/2024 Positive
Orphan designation: Humanised IgG1 (K322A) monoclonal antibody against disialoganglioside GD2 Treatment of neuroblastoma, 16/04/2024 Positive
Orphan designation: Autologous adipose-derived mesenchymal stem cells embedded in an extracellular matrix with hydroxyapatite/beta-tricalcium phosphate particles Treatment of congenital pseudarthrosis of long bones, 16/04/2024 Positive
Orphan designation: Autologous adipose-derived stem cells Treatment of spinal cord injury, 16/04/2024 Positive